Compare CDTX & PRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDTX | PRK |
|---|---|---|
| Founded | 2012 | 1908 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2015 | N/A |
| Metric | CDTX | PRK |
|---|---|---|
| Price | $220.50 | $162.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 3 |
| Target Price | $128.75 | ★ $178.00 |
| AVG Volume (30 Days) | ★ 2.3M | 68.7K |
| Earning Date | 11-06-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | N/A | ★ 28.24 |
| EPS | N/A | ★ 10.85 |
| Revenue | N/A | ★ $535,826,000.00 |
| Revenue This Year | N/A | $10.95 |
| Revenue Next Year | N/A | $12.58 |
| P/E Ratio | ★ N/A | $15.11 |
| Revenue Growth | N/A | ★ 10.64 |
| 52 Week Low | $15.22 | $137.97 |
| 52 Week High | $221.20 | $190.59 |
| Indicator | CDTX | PRK |
|---|---|---|
| Relative Strength Index (RSI) | 86.62 | 64.73 |
| Support Level | $219.60 | $156.97 |
| Resistance Level | $220.38 | $166.53 |
| Average True Range (ATR) | 0.74 | 3.94 |
| MACD | -3.92 | 1.19 |
| Stochastic Oscillator | 67.82 | 85.46 |
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. Park National provides banking and other financial services to consumers and businesses.